New recommendations for contact tracing in tuberculosis: German Central Committee against Tuberculosis;Neue empfehlungen für die umgebungsuntersuchungen bei tuberkulose: Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose

Pneumologie

Volumn 65, Issue 6, 2011, Pages 359-378

  Diel, R ^a   Loytved, G ^b   Nienhaus, A ^c   Castell, S ^a   Detjen, A ^d   Geerdes Fenge, H ^e   Haas, W ^f   Hauer, B ^f   Konigstein B ^b   Maffei, D ^b   Magdorf, K ^g   Priwitzer, M ^b   Zellweger, J P ^h   Loddenkemper, R ^a  

^a Deutsches Zentralkomitee Zur Bekampfung der Tuberkulose   (Germany)

^b Landratsamt Würzburg Gesundheitsamt ^*  (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^e ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^f ROBERT KOCH INSTITUTE   (Germany)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h Lungenliga Schweiz   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

BCG VACCINATION; CHEMOPROPHYLAXIS; CONTACT EXAMINATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; GERMANY; HUMAN; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; PRIORITY JOURNAL; PROBABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ADULT; AGE FACTORS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; BCG VACCINE; CHILD; CHILD, PRESCHOOL; CONTACT TRACING; GERMANY; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TUBERCULIN TEST; TUBERCULOSIS; YOUNG ADULT;

EID: 79958784102     PISSN: 09348387     EISSN: 14388790     Source Type: Journal    
DOI: 10.1055/s-0030-1256439     Document Type: Review

References (120)

1. Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (DZK). Empfehlungen für die Umgebungsuntersuchungen bei Tuberkulose. Gesundheitswesen 2007; 69: 488-503
2. RKI. Falldefinitionen des Robert Koch-Instituts zur Übermittlung von Erkrankungs- oder Todesfällen und Nachweisen von Krankheitserregern, Ausgabe 2007
3. Templeton GL, Illing LA, Young L et al. The risk of transmission of Mycobacterium tuberculosis at the bedside and during autopsy. Ann Int Med 1995; 122: 922-925
4. Riley RL. The contagiosity of tuberculosis. Schweiz Med Wochenschr 1983; 113: 75-79
5. Diel R, Schneider S, Meywald-Walter K et al. Epidemiology of tuberculosis in Hamburg, Germany: long-term population-based analysis applying classical and molecular epidemiological techniques. J Clin Microbiol 2002; 40: 532-539 (Pubitemid 34130878)
6. Behr MA,Warren SA, Salamon H et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999; 353: 444-449 (Pubitemid 29067335)
7. Loudon RG, Spohn SK. Cough frequency and infectivity in patients with pulmonary tuberculosis. Am Rev Resp Dis 1969; 99: 109-111
8. Loudon RG, Roberts RM. Droplet expulsion from the respiratory tract. Am Rev Respir Dis 1966; 95: 435-442
9. Curtis AB, Ridzon R, Vogel R et al. Extensive transmission of Mycobacterium tuberculosis from a child. N Engl J Med 1999; 341: 1491-1495 (Pubitemid 29526351)
10. Sultan L, Nyka W, Mills C et al. Tuberculosis disseminators: a study of the variability of aerial infectivity of tuberculosis patients. Am Rev Respir Dis 1960; 82: 358-369
11. Kenyon TA, Valway SE, IhleWWet al. Transmission of multidrug-resistant Mycobacterium tuberculosis during a long airplane flight. N Engl J Med 1996; 334: 933-938 (Pubitemid 26114158)
12. Behr MA, Hopewell PC, Paz EA et al. Predictive value of contact investigation for identifying recent transmission of Mycobacterium tuberculosis. Am J Respir Crit Care Med 1998; 158: 465-469 (Pubitemid 28378174)
13. Diel R, Seidler A, Nienhaus A et al. Occupational risk of tuberculosis transmission in a low incidence area. Resp Res 2005; 6: 35
14. Veen J. Microepidemics of tuberculosis: the stone-in-the-pond principle. Tuber Lung Dis 1992; 73: 73-76
15. Khan EA, Starke JR. Diagnosis of tuberculosis in children: increased need for better methods. Emerg Infect Dis 1995; 1: 115-123
16. Elwood RK, Cook JK, Hernández-Garduño E. Risk of tuberculosis in children from smear-negative source cases. Int J Tuberc Lung Dis 2005; 9: 49-55 (Pubitemid 40095109)
17. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161: S221-S247
18. Keane J, Gershon S, Wise RP et al. Tuberculosis associated with infliximab, a tumor necrosis α-neutralizing agent. N Engl J Med 2001; 354: 1098-1104
19. Morgenroth K, Schnabel R. Pathogenese und Pathomorphologie der Tuberkulose. In: Konietzko N, Loddenkemper R, Hrsg. Tuberkulose. Stuttgart: Thieme; 1999
20. Wallgren A. Time-table of tuberculosis. Tubercle 1948; 29: 250-253
21. Comstock G, Edwards P. The competing risks for tuberculosis and hepatitis for adult tuberculin reactors. Am Rev Respir Dis 1975; 111: 5763-577
22. Tufariello JM, Chan J, Flynn JL. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infec Dis 2003; 3: 578-590 (Pubitemid 37064537)
23. Marks GB, Bai J, Simpson SE et al. Incidence of tuberculosis among a cohort of tuberculin-positive refugees in Australia: reappraising the estimates of risk. Am J Resp Crit Care Med 2000; 162: 1851-1854
24. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis - A general review. Adv Tuberc Res 1970; 18: 28-106
25. Sutherland I. Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. Adv Tuberc Res 1976; 19: 1-63
26. Neumann G. Aufgaben des Gesundheitsamtes bei der Tuberkulose- bekämpfung. Öff Gesund-Wes 1985; 47: 98-100
27. Weis SE, Pogada JM, Yang Z et al. Transmission dynamics of tuberculosis in Tarrant County. Am J Respir Crit Care Med 2002; 166: 36-42 (Pubitemid 34693960)
28. Small PM, Hopewell PC, Singh SP et al. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med 1994; 330: 1703-1709
29. Van Soolingen D, BorgdorffMW, de Haas PE et al. Molecular epidemiology of tuberculosis in The Netherlands: a nationwide survey from 1993 through 1997. J Infect Dis 1999; 180: 726-736
30. Alland D, Kalkut GE, Moss AR et al. Transmission of tuberculosis in New York City: an analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994; 330: 1710-1716
31. Van Deutekom H, Gerritsen JJ, van Soolingen D et al. A molecular epidemiological approach to studying the transmission of tuberculosis in Amsterdam. Clin Infect Dis 1997; 25: 1071-1077 (Pubitemid 27513189)
32. Braden CR, Templeton GL, Cave MD et al. Interpretation of restriction fragment length polymorphism analysis in M. tuberculosis isolates from a state with a large rural population. J Infect Dis 1997; 175: 1446-1452 (Pubitemid 27225049)
33. Sebek M. DNA fingerprinting and contact investigation. Int J Tuberc Lung Dis 2000; 4: S45-S48 (Pubitemid 30121052)
34. Seidler A, Diel R. Aspekte der beruflichen Übertragung der Tuberkulose im Lichte neuer molekularbiologischer Ansätze. In: Nienhaus A, Brandenburg S, Teschler H, Hrsg. Tuberkulose als Berufskrankheit. Landsberg: ecomed; 2003
35. Robert Koch-Institut. Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2009. Berlin: 2011
36. American Thoracic Society (ATS), Centers for Disease Control and Prevention (CDC), American Academy of Pediatrics and Infectious Disease Society of America. Control of tuberculosis in the United States. Am Rev Resp Dis 1992; 118: 1623-1633
37. British Thoracic and Tuberculosis Association. A study of a standardised contact procedure in tuberculosis. Tubercle 1978; 59: 245-259
38. Köhler H. Übertragung einer Tuberkulose auf dem Genitalwege. Zschr Urol 1973; 66: 207-209
39. Diel R, Meywald-Walter K, Gottschalk R et al. Ongoing outbreak of tuberculosis in a low-incidence community: amolecular-epidemiological evaluation. Int J Tuberc Lung Dis 2004; 8: 855-861 (Pubitemid 38937602)
40. Bales S, Baumann HG, Schnitzler N. Kommentar zum Infektionsschutzgesetz - IfSG. Köln: W. Kohlhammer; 2000
41. Erdle H. Das Infektionsschutzgesetz, Kommentar. Landsberg/Lech: ecomed; 2000
42. Anonymus. Die Tätigkeit des Gesundheitsamtes bei der Tuberkulosefürsorge. VersR 1959; 353-355
43. Anonymus. Verordnung über den Schutz vor Schäden durch Röntgenstrahlen (Röntgenverordnung - RöV). BGBl I vom 8.1.1987; 114-133
44. Anonymus. Verordnung zur Änderung der Röntgenverordnung und anderer atomrechtlicher Verordnungen (RöV). BGBl I vom 21. 6. 2002; 1869ff
45. Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (DZK). Das Strahlenrisiko bei Röntgenuntersuchungen des Thorax. Pneumologie 2001; 55: 57-71
46. Kaufmann SHE. Die Immunantwort gegen Tuberkulose. In: Konietzko N, Loddenkemper R, Hrsg. Tuberkulose. Stuttgart: Thieme; 1999
47. Singh D, Sutton C, Woodcock A. Tuberculin test measurement - variability due to the time of reading. Chest 2002; 122: 1299-1301 (Pubitemid 35339544)
48. Youssef E, Wooltorton E. Serious allergic reactions following tuberculin skin tests. CMAJ 2005; 173: 34 (Pubitemid 40980937)
49. Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion and reversion. Am J Respir Crit Care Med 1999; 159: 15-21 (Pubitemid 29036497)
50. Poulsen A. Some clinical features of tuberculosis. 1. Incubation period. Acta Tuberc Scand 1950; 24: 311-346
51. Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (DZK). Richtlinien zur Tuberkulindiagnostik. Dt Ärztebl 1996; 93: 1199-1201
52. Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004; 350: 2060-2079
53. Lange C, Schaberg T, Diel R et al. Aktueller Stand der Tuberkulosediagnostik. DMW2006; 131: 341-347
54. Comstock GW. Identification of an effective vaccine against tuberculosis. Am Rev Respir Dis 1988; 138: 479-480
55. Tissot F, Zanetti G, Francioli P et al. Influence of Bacille Calmette-Guérin vaccination on size of tuberculin skin test reaction: to what size? Clin Inf Dis 2005; 40: 211-217
56. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340-354 Erratum in: Ann Intern Med 2007; 146: 688
57. Mori T, Sakatani M, Yamagishi F et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004; 170: 59-64 (Pubitemid 38997752)
58. Diel R, Goletti D, Ferrara G et al. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 2011; 37: 88-99
59. Simon K, Gutland M. Die Tuberkulinprobe in der Klinik - Dosierung undWertung. Prax Klin Pneumol 1988; 42: 423-426
60. Cole ST, Brosch R, Parkhill J et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998; 393: 537-544 Erratum in: Nature 1998; 396: 190 (Pubitemid 28523625)
61. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: Part 1. Latent tuberculosis. Expert Rev Mol Diagn 2006; 6: 413-422 (Pubitemid 44174345)
62. Anibarro L, Trigo M, Villaverde C et al. Interferon-? release assays in tuberculosis contacts: is there a window period? Eur Respir J 2011; 37: 215-217
63. Lee SW, Oh DK, Lee SH et al. Time interval to conversion of interferon-{gamma} release assay after exposure to tuberculosis. Eur Respir J 2010 Dec 9 [Epub ahead of print]
64. Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest 2010; 137: 952-968
65. Sester M, Sotgiu G, Lange C et al. Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic reviewand meta-analysis. Eur Respir J 2011; 37: 100-111
66. Hoffmann M, Raven P. The use of Interferon-gamma Release assays in HIV-positive individuals. Eur Infect Dis 2010; 4: 23-29
67. Pai M, Zwerling A, Menzies D. Systematic review: T-cell based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008; 149: 177-184
68. Bamford AR, Crook AM, Clark JE et al. Comparison of Interferon-gamma release assays and Tuberculin Skin Test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB Network Study. Arch Dis Child 2010; 95: 180-186 [Epub 2009 Oct 8]
69. Bianchi L, Galli L, Moriondo M et al. Interferon-gamma release assay improves the diagnosis of tuberculosis in children. Pediatr Infect Dis J 2009; 28: 510-514
70. Connell TG, Ritz N, Paxton GA et al. A three-way comparison of tuberculin skin testing, QuantiFERON-TB Gold and T-Spot.TB in children. PLos One 2008; 3: e2624
71. Cruz AT, Geltemeyer AM, Starke JR et al. Comparing the tuberculin skin test and T-SPOT.TB blood test in children. Pediatrics 2011; 127: e31-e38 [Epub 2010 Dec 6]
72. Detjen AK, Keil T, Roll S et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007; 45: 322-328 (Pubitemid 47101028)
73. Kampmann B, Whittaker E, Williams A et al. Interferon-gamma release assays do not identify more children with active TB than TST. Eur Respir J 2009; 33: 1374-1382
74. Nicol MP, DaviesMA,Wood K et al. Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting. Pediatrics 2009; 123: 38-43
75. Bienek DR, Chang CK. Evaluation of an interferon-gamma release assay, T-SPOT.TB, in a population with a low prevalence of tuberculosis. Int J Tuberc Lung Dis 2009; 13: 1416-1421
76. Wang SH, Powell DA, Nagaraja HN et al. Evaluation of amodified interferon-gamma release assay for the diagnosis of latent tuberculosis infection in adult and paediatric populations that enables delayed processing. Scand J Infect Dis 2010; 42: 845-850
77. Aichelburg MC, Rieger A, Breitenecker F et al. Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. Clin Infect Dis 2009; 48: 954-962
78. Clark SA, Martin SL, Pozniak A et al. Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin Exp Immunol 2007; 150: 238-244 (Pubitemid 47609557)
79. Diel R, Loddenkemper R, Niemann S et al. Negative and positive predictive value of a whole-blood interferon-{gamma} release assay for dveloping active tuberculosis: An update. Am J Respir Crit Care Med 2011; 183: 88-95
80. Haldar P, Thuraisingham H, Hoskyns W, Woltmann G. Contact screening with single-step TIGRA testing and risk of active TB infection: The Leicester cohort analysis. Thorax 2009; 64 (Suppl. 4): A10
81. Kik SV, Franken WP, Mensen M et al. Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur Respir J 2010; 35: 1346-1353
82. Diel R, Schaberg T, Loddenkemper R et al. Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany. Respir Med 2009; 103: 1838-1853
83. Diel R, Wrighton-Smith P, Zellweger JP. Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis. Eur Respir J 2007; 30: 321-332 (Pubitemid 47194185)
84. Rangaka MX, Wilkinson K, Seldon R et al. The effect of HIV-1 infection on T cell based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 2007; 175: 514-529
85. Liebeschuetz S, Bamber S, Ewer K et al. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 2004; 364: 2196-2039
86. Passalent L, Khan K, Richardson R. Detecting latent tuberculosis infection in hemodialysis patients: A head-to-head comparison of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel. Clin J Am Soc Nephr 2007; 2: 68-73
87. Diel R, Hauer B, Loddenkemper R et al. Empfehlungen für das Tuberkulosescreening vor Gabe von TNF-α-Inhibitoren bei rheumatischen Erkrankungen. Pneumologie 2009; 63: 329- 334
88. und Z Rheumatol 2009; 68: 411-416
89. Meyer M, Clarke P, O'Regan AW. Utility of the lateral chest radiograph in the evaluation of patients with a positive tuberculin skin test result. Chest 2003; 124: 1824-1827 (Pubitemid 37433579)
90. Tuberculosis coalition for technical assistance. International standards for tuberculosis care (ISTC). The Hague: Tuberculosis coalition for technical assistance. 2006
91. National Institute for Clinical Excellence (NICE). Tuberculosis. National clinical guideline for diagnosis, management, prevention, and control. March 2006 www.nice.org.uk. Stand: 1. 4.2011
92. Centers for Disease Control and Prevention. Guidelines for the investigation of contacts of persons with infectious tuberculosis: Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR 2005; 54 (RR-15): 1-37
93. World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva: 2006 (WHO/HTM/TB/2006. 371)
94. Magdorf K, Fehn T, Griese M et al. Tuberkulose und nichttuberkulöse mykobakterielle Krankheiten. In: Deutsche Gesellschaft für pädiatrische Infektiologie e. V. (DGPI), Hrsg. DGPI Handbuch: Infektionen bei Kindern und Jugendlichen. Stuttgart: Georg Thieme; 2009
95. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 2000; 49 (RR-6): 1-51
96. Schaberg T, Castell S, Dalhoff K et al. Empfehlungen zur medikamentösen Therapie der Tuberkulose im Erwachsenen- und Kindesalter. Pneumologie 2011 [in Vorbereitung]
97. Nardell EA, Wallis RS. Here today - gone tomorrow: the case for transient acute tuberculosis infection. Am J Respir Crit Care Med 2006; 174: 734-735 (Pubitemid 44511653)
98. Centers for Disease Control and Prevention. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 2010; 59 (RR-5): 1-25
99. Perry S, Parsonnet J. Commentary: H. pylori infection in early life and the problem of imperfect tests. Int J Epidemiol 2005; 34: 1356-1358 (Pubitemid 41819544)
100. Perry S, Sanchez L, Yang S et al. Reproducibility of QuantiFERON-TB gold in-tube assay. Clin Vaccine Immunol 2008; 15: 425-432 (Pubitemid 351967072)
101. Ewer K, Millington KA, Deeks JJ et al. Dynamic antigen-specific T cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 2006; 174: 831-839 (Pubitemid 44511666)
102. Friedman LN, Nash ER, Bryant J et al. High rate of negative results of tuberculin and QuantiFERON tests among individuals with a history of positive skin test results. Infect Control Hosp Epidemiol 2006; 27: 436-441 (Pubitemid 43835523)
103. Shams H, Weis SE, Klucar P et al. Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am J Respir Crit Care Med 2005; 172: 1161-1168 (Pubitemid 43066653)
104. Loytved G. Umgebungsuntersuchungen in Schulen. Tuberkulintestung am Friedrich Dessauer Gymnasium Aschaffenburg. Vortragsmanuskript vom 17. 11.2004
105. RKI. Erfahrungsbericht: Tuberkulose in einer Klasse einer Mittelschule. Epid Bull 2004; 44: 377
106. RKI. Hinweise für Ärzte, Leitungen von Gemeinschaftseinrichtungen und Gesundheitsämter zur Wiederzulassung in Schulen und sonstigen Gemeinschaftseinrichtungen. Aktualisierte Fassung vom 25. Juli 2006. Erstveröffentlichung im Bundesgesundhbl - Gesundhforsch - Gesundhschutz 2001; 44: 830-841
107. RKI. Tuberkulose in großen Gemeinschaften. Beispiele der Handhabung von Umgebungsuntersuchungen. Epid Bull 2001; 41: 25-29
108. Verordnung zur Umsetzung von EG-Richtlinien über den Schutz der Beschäftigten gegen Gefährdung durch biologische Arbeitsstoffe bei der Arbeit (BioStoffV) vom 27. 01. 1999. BGBl I: 50-60
109. Kollecker S. Zur Frage der Anzeigepflicht von Ärzten bei der Tuberkulinkonversion. In: Nienhaus A, Brandenburg S, Teschler H, Hrsg. Tuberkulose als Berufskrankheit. Landsberg: ecomed; 2003
110. Nienhaus A, Loddenkemper R, Hauer B et al. Latente Tuberkulose- Infektionen im Gesundheitswesen - Evaluation des Interferon-γ Release Assay. Pneumologie 2007; 61: 219-222
111. Torres Costa J, Sá R, Cardoso MJ et al. Tuberculosis screening in Portuguese healthcare workers using the Tuberculin Skin Test and the Interferon-γ release assay. Eur Resp J 2009; 34: 1423-1428
112. MiQ. Mikrobiologisch-infektiologische Qualitätsstandards (MiQ) 5-Tuberkulose, Mykobakteriose. München: Elsevier; 2010
113. RKI. Zu einer ausgedehnten Tuberkulosehäufung im Wohn- und Arbeitsumfeld von Behinderten. Epid Bull 2004; 44: 378-379
114. Kendig N. Tuberculosis control in prisons. Int J Tuberc Lung Dis 1998; 2: S57-S63
115. World Health Organization. Tuberculosis and air travel. Guidelines for prevention and control; 3rd edition Geneva: 2008 (WHO/HTM/TB/2009.399)
116. ECDC technical report. Risk assessment guidelines for infectious diseases transmitted on aircraft. Stockholm: 2009 http://www.ecdc.europa.eu/en/ publications/Publications/0906-TER-Risk-Assessment-Guidelines-for-Infectious- Diseases-Transmitted-on-Aircraft.pdf. Stand: 1. 4.2011
117. Gronauer W, Pregler M, Wolf P. Bemerkenswerte Tuberkulose-Kleinepidemien 2001/2002 in zwei bayerischen Regierungsbezirken. Pneumologie 2004; 58: 9-16
118. Hauer B, Kunitz F, Sagebiel D et al. Untersuchungen zur Tuberkulose in Deutschland: Molekulare Epidemiologie, Resistenzsituation und Behandlung (überarbeiteter Abschlussbericht zur DZK-Studie). Berlin: DZK; 2006
119. Malakmadze N, González IM, Oemig T et al. Unsuspected recent transmission of tuberculosis among high-risk groups: implications of universal tuberculosis genotyping in its detection. Clin Infect Dis 2005; 40: 366-373 (Pubitemid 40216503)
120. De Vries G, van Hest RA, Burdo CC et al. AMycobacterium tuberculosis cluster demonstrating the use of genotyping in urban tuberculosis control. BMC Infect Dis 2009; 9: 151